-
1
-
-
30744446828
-
-
World Health Organization: Geneva
-
Fact Sheet No. 138; World Health Organization: Geneva, 2002.
-
(2002)
Fact Sheet No. 138
-
-
-
4
-
-
3843072211
-
-
(b) Weber, A. E. J. Med. Chem. 2004, 47, 4135-4141.
-
(2004)
J. Med. Chem
, vol.47
, pp. 4135-4141
-
-
Weber, A.E.1
-
6
-
-
0037397603
-
-
(d) Augustyns, K.; Van der Veken, P.; Senten, K.; Haemers, A. Expert Opin. Ther. Pat. 2003, 13, 499-510.
-
(2003)
Expert Opin. Ther. Pat
, vol.13
, pp. 499-510
-
-
Augustyns, K.1
Van der Veken, P.2
Senten, K.3
Haemers, A.4
-
7
-
-
58149148624
-
-
Lee, C.-S.; Koo, K. D.; Koh, J. S.; Kim, S.; Kim, D.-M.; Kim, M.-J.; Kim, B. C.; Yoon, S. K.; Kim, S.; Yim, H. J.; Hur, G.-C.; Lee, S. H.; Han, H. O.; Kim, K.-H.; Kim, G. T.; Kwon, O. H.; Kwon, T.-S.; Lee, H. B.; Chung, H. K.; Kim, M.; Lim, D.; Kim, Y. C.; Kim, S. PCT Int. Appl. WO2005037828, 2005.
-
(a) Lee, C.-S.; Koo, K. D.; Koh, J. S.; Kim, S.; Kim, D.-M.; Kim, M.-J.; Kim, B. C.; Yoon, S. K.; Kim, S.; Yim, H. J.; Hur, G.-C.; Lee, S. H.; Han, H. O.; Kim, K.-H.; Kim, G. T.; Kwon, O. H.; Kwon, T.-S.; Lee, H. B.; Chung, H. K.; Kim, M.; Lim, D.; Kim, Y. C.; Kim, S. PCT Int. Appl. WO2005037828, 2005.
-
-
-
-
8
-
-
34347369279
-
-
(b) Koo, K. D.; Kim, M. J.; Kim, S.; Kim, K.-H.; Kong, S. Y.; Hur, G.-C.; Yim, H. J.; Kim, G. T.; Han, H. O.; Kwon, O. H.; Kwon, T. S.; Koh, J. S.; Lee, C.-S. Bioorg. Med. Chem. Lett. 2007, 17, 4167.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 4167
-
-
Koo, K.D.1
Kim, M.J.2
Kim, S.3
Kim, K.-H.4
Kong, S.Y.5
Hur, G.-C.6
Yim, H.J.7
Kim, G.T.8
Han, H.O.9
Kwon, O.H.10
Kwon, T.S.11
Koh, J.S.12
Lee, C.-S.13
-
10
-
-
0035125164
-
-
Ohmoto, K.; Yamamoto, T.; Horiuchi, T.; Kojima, T.; Hachiya, K.; Hashimoto, S.; Kawamura, M.; Nakai, H.; Toda, M. Synlett 2001, 299.
-
(2001)
Synlett
, pp. 299
-
-
Ohmoto, K.1
Yamamoto, T.2
Horiuchi, T.3
Kojima, T.4
Hachiya, K.5
Hashimoto, S.6
Kawamura, M.7
Nakai, H.8
Toda, M.9
-
11
-
-
0035848574
-
-
Ohmoto, K.; Yamamoto, T.; Okuma, M.; Horiuchi, T.; Imanishi, H.; Odagaki, Y.; Kawabata, K.; Sekioka, T.; Hirota, Y.; Matsuoka, S.; Nakai, H.; Toda, M. J. Med. Chem. 2001, 44, 1268.
-
(2001)
J. Med. Chem
, vol.44
, pp. 1268
-
-
Ohmoto, K.1
Yamamoto, T.2
Okuma, M.3
Horiuchi, T.4
Imanishi, H.5
Odagaki, Y.6
Kawabata, K.7
Sekioka, T.8
Hirota, Y.9
Matsuoka, S.10
Nakai, H.11
Toda, M.12
-
12
-
-
58149143530
-
-
2 or dichloroethane (1.0 L and 500 mL, based on 1.0 L of 75% aqueous oxazolidine) and used after concentration.
-
2 or dichloroethane (1.0 L and 500 mL, based on 1.0 L of 75% aqueous oxazolidine) and used after concentration.
-
-
-
-
13
-
-
0028819304
-
-
Falorni, M.; Conti, S.; Giacomelli, G.; Cossu, S.; Soccolini, F. Tetrahedron: Asymmetry 1995, 6, 287.
-
(1995)
Tetrahedron: Asymmetry
, vol.6
, pp. 287
-
-
Falorni, M.1
Conti, S.2
Giacomelli, G.3
Cossu, S.4
Soccolini, F.5
-
14
-
-
58149176352
-
-
2O = 3:97 containing 0.1% TFA as an eluent at 254 nm; retention times of trans- and cis-1 were 10.9 and 17.8 min, respectively.
-
2O = 3:97 containing 0.1% TFA as an eluent at 254 nm; retention times of trans- and cis-1 were 10.9 and 17.8 min, respectively.
-
-
-
-
15
-
-
33745753177
-
-
For an excellent review, see
-
For an excellent review, see: Anderson, N. G. Org. Process Res. Dev. 2006, 10, 683.
-
(2006)
Org. Process Res. Dev
, vol.10
, pp. 683
-
-
Anderson, N.G.1
-
16
-
-
58149151759
-
-
Please refer to ref 7
-
Please refer to ref 7.
-
-
-
|